Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

actisomide

Known as: 4-(2-(bis(1-methylethyl)amino)ethyl)-4,4a,5,6,7,8-hexahydro-1-methyl-4-phenyl-3H-pyrido(1,2-c)pyrimidin-3-one 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1999
1999
Pharmacokinetic parameters (clearance, CL, volume of distribution in the central compartment, VdC, and elimination half-life, t1… Expand
Is this relevant?
1993
1993
The pharmacokinetics of a novel antiarrhythmic drug, actisomide, were examined in the rat, dog, monkey, and human. The terminal… Expand
Is this relevant?
1992
1992
SummaryThe metabolism of actisomide, a novel antiarrhythmic agent, was studied in the dog, monkey and man and was found to be… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
1991
1991
The pharmacokinetics and tolerance of actisomide (SC-36602) were determined following intravenous doses of 2.1, 4.2, and 8.4 mg… Expand
  • table 1
  • figure I
  • table 2
  • table 3
Is this relevant?